South Africa launches bid to enable local production of long-acting HIV prevention drug, lenacapavir
Unitaid and USP provide technical and market support to strengthen regional manufacturing and supply resilience The Government of South Africa today announced that it is engaging with Gilead Sciences to pursue an agreement that would enable local production of lenacapavir, a revolutionary long-acting HIV prevention drug. As part of this...